Skip to main content
OpenTrials

Clinical trial condition

Bronchiolitis

Explore clinical trials studying Bronchiolitis. Study availability and eligibility vary by location and protocol.

583 public trials 92 recruiting studies
Refine in advanced search Browse all conditions

Bronchiolitis trial results

Completed

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

NCT02513498

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Completed

Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease

NCT02491359

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01241591

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations
  • Centro de Investigaciones Dermatologicas Buenos Aires, C1114aap, Argentina
  • Centro de Investigaciones Dermatologicas Buenos Aires, Argentina
  • IMAI (Instituto Medico de Asistencia e Investigaciones) Buenos Aires, Argentina
  • LKH Feldkirch Abteilung fuer Dermatologie und Venerologie Feldkirch, Austria
View all 122 locations
View Trial Details
Completed

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01186744

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • Horizon Research Group, Inc. Mobile, Alabama, United States
  • Radiant Research, Inc. Tucson, Arizona, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Associates In Research, Inc. Fresno, California, United States
View all 87 locations
View Trial Details
Completed

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

NCT03485846

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • FBIS CSRI of Epidemiology of Federal Service on Customers Moscow, Russia
  • SBEI HPE Moscow State Medical and Dental University n.a. A.I. Evdokimov of Ministry of Health of Russia Moscow, Russia
  • SBHI of Moscow "City Clinical Hospital #24" Moscow, Russia
  • St. Petersburg SBHI Center of Prevention and Fight against AIDS and Infection Diseases Saint Petersburg, Russia
View Trial Details
Completed

Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

NCT01106833

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
View all 31 locations
View Trial Details
Completed

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

NCT01313689

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Salzburg, Austria
View all 80 locations
View Trial Details

Related conditions